An antibody cocktail is now beginning late-stage clinical trials to evaluate the drug's ability to prevent and treat coronavirus infection.
The post Regeneron Starts Phase 3 Trial Of Covid Antibody Drug That Might Treat And Prevent Infection appeared first on The Seattle Medium.